It has a greater emphasis on smaller companies that could help this equal-weight strategy outperform if there is increased M&A activity.
Click here to listen to the podcast.
Related:
Big Biotech ETF Bounce Looks for More Upside
Biotech ETFs Could Heat Up Thanks to Republican-Led Congress